Drug Search Results
More Filters [+]

Epoetin omega

Alternative Names: epoetin omega
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: N/A

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Baxter Healthcare
Company Location: DEERFIELD IL 60015
Company CEO: José E. Almeida
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Epoetin omega

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Kidney Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Epomax (1 x / week s.c.) A dose dependency evaluation

P2

Completed

Kidney Diseases

2005-11-19

Epomax (3 x week i.v.) A dose dependency evaluation

P2

Completed

Kidney Diseases

2005-09-01

Recent News Events

Date

Type

Title